Literature DB >> 25376494

Dual roles of orphan nuclear receptor TR3/Nur77/NGFI-B in mediating cell survival and apoptosis.

Gengming Niu1, Lei Lu2, Jun Gan1, Di Zhang3, Jingzheng Liu4, Guangjian Huang1.   

Abstract

As a transcriptional factor, Nur77 has sparked interests across different research fields in recent years. A number of studies have demonstrated the functional complexity of Nur77 in mediating survival/apoptosis in a variety of cells, including tumor cells. Conflicting observations also exist in clinical reports, in that TR3 behaves like an oncogene in tumors of the GI tract, lung, and breast, that is negatively associated with tumor stage and patient prognosis; while functions as a tumor suppressor gene in malignancies of the hematological and lymphatic system, skin, and ovary whose malfunction results in carcinogenesis. This chapter summarizes the apparent opposing effects of Nur77 on cells and explicates the mechanisms that determine the functional preference of Nur77. We conclude that in addition to cell type and agent context, other factors such as cellular localization, signaling pathway, and posttranslational modification also determine the final effects of Nur77 on cells.

Entities:  

Keywords:  Cancer; Cell death; Cell survival; Clinical therapy; Signal pathway; TR3/Nur77/NGFI-B

Mesh:

Substances:

Year:  2014        PMID: 25376494     DOI: 10.1016/B978-0-12-800177-6.00007-4

Source DB:  PubMed          Journal:  Int Rev Cell Mol Biol        ISSN: 1937-6448            Impact factor:   6.813


  10 in total

1.  DLL4 and Jagged1 are angiogenic targets of orphan nuclear receptor TR3/Nur77.

Authors:  Jin Peng; Shengqiang Zhao; Yan Li; Gengming Niu; Chen Chen; Taiyang Ye; Dezheng Zhao; Huiyan Zeng
Journal:  Microvasc Res       Date:  2019-03-28       Impact factor: 3.514

2.  High expression of orphan nuclear receptor NR4A1 in a subset of ovarian tumors with worse outcome.

Authors:  Evan Delgado; Michelle M Boisen; Robin Laskey; Rui Chen; Chi Song; Jad Sallit; Zachary A Yochum; Courtney L Andersen; Matthew J Sikora; Jacob Wagner; Stephen Safe; Esther Elishaev; Adrian Lee; Robert P Edwards; Paul Haluska; George Tseng; Mark Schurdak; Steffi Oesterreich
Journal:  Gynecol Oncol       Date:  2016-03-11       Impact factor: 5.482

Review 3.  Characteristics of Nur77 and its ligands as potential anticancer compounds (Review).

Authors:  Lingjuan Wu; Liqun Chen
Journal:  Mol Med Rep       Date:  2018-09-27       Impact factor: 2.952

4.  Human Menstrual Blood-Derived Stromal Cells Promote Recovery of Premature Ovarian Insufficiency Via Regulating the ECM-Dependent FAK/AKT Signaling.

Authors:  Penghui Feng; Pingping Li; Jichun Tan
Journal:  Stem Cell Rev Rep       Date:  2019-04       Impact factor: 5.739

5.  Nuclear receptor 4A1 (NR4A1) silencing protects hepatocyte against hypoxia-reperfusion injury in vitro by activating liver kinase B1 (LKB1)/AMP-activated protein kinase (AMPK) signaling.

Authors:  Yu Zheng; Yingying Tao; Xiaobo Zhan; Qi Wu
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

Review 6.  Therapeutic potential of NR4A1 in cancer: Focus on metabolism.

Authors:  Shan Deng; Bo Chen; Jiege Huo; Xin Liu
Journal:  Front Oncol       Date:  2022-08-16       Impact factor: 5.738

7.  Ethyl Acetate Fraction of Hedyotis diffusa Willd Induces Apoptosis via JNK/Nur77 Pathway in Hepatocellular Carcinoma Cells.

Authors:  Weimin Ning; Nishan Xu; Chunhong Zhou; Lifang Zou; Jingyu Quan; Hua Yang; Zinbin Lu; Huihui Cao; Junshan Liu
Journal:  Evid Based Complement Alternat Med       Date:  2022-08-24       Impact factor: 2.650

8.  NR4A1 inhibition synergizes with ibrutinib in killing mantle cell lymphoma cells.

Authors:  Yangguang Li; Fangyu Wang; Li Lu; Fen Zhu; Shengjian Huang; Krystle Nomie; Liang Zhang; David T Yang; Wei Huang; Brad S Kahl; Stephen Safe; Michael Wang; Lixin Rui
Journal:  Blood Cancer J       Date:  2017-11-23       Impact factor: 11.037

Review 9.  The Orphan Nuclear Receptor 4A1: A Potential New Therapeutic Target for Metabolic Diseases.

Authors:  Lei Zhang; Qun Wang; Wen Liu; Fangyan Liu; Ailing Ji; Yanzhang Li
Journal:  J Diabetes Res       Date:  2018-06-14       Impact factor: 4.011

10.  β-glucan from Lentinus edodes inhibits breast cancer progression via the Nur77/HIF-1α axis.

Authors:  Xiuru Zhang; Tingting Li; Shuwen Liu; Yiming Xu; Minjun Meng; Xiumin Li; Zhichao Lin; Qici Wu; Yu Xue; Yutian Pan; Gulimiran Alitongbieke
Journal:  Biosci Rep       Date:  2020-12-23       Impact factor: 3.840

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.